semaglutide can you stop taking it What Happens After for Weight Loss? – PlexusDx What happens when patients stop

Circ J 80(9):19881997

The cardiovascular benefits observed with these medications include: Reduction in non-fatal myocardial infarction and stroke Decreased cardiovascular mortality in high-risk populations (demonstrated with liraglutide) Improvements in blood pressure and lipid profiles Weight reduction , which independently lowers cardiovascular risk It is important to distinguish between arterial thrombotic events (such as heart attacks and strokes, which some GLP-1 agonists help prevent) and venous thromboembolism (DVT and PE)

Candidates should also: Be non-smokers, or willing to quit prior to beginning treatment Live a healthy lifestyle, including an exercise program and a healthy diet Understand the risks of the treatment Have a positive outlook and realistic goals Be prepared to closely follow instructions Cannot have a history of thyroid cancer or Multiple Endocrine Neoplasia (MEN) syndrome Cannot have a history of intestinal obstruction It is important to note that compounded GLP-1 Therapy treatments are just a portion of a successful weight loss program

Interestingly, the neural circuits responsible for the metabolic effects of GLP-1R agonism may be distinct from those mediating nausea or malaise (Huang et al., 2024), suggesting that future therapies could be tailored to preserve metabolic benefits while minimizing gastrointestinal side effects

Why choose Claya

For instance, in patients with insulinoma, 68 Ga-labeled exendin PET imaging can identify tumor burden and GLP-1R expression patterns, guiding subsequent administration of the same nanoplatform conjugated to 177 Lu for targeted radiotherapy